Your browser doesn't support javascript.
loading
Combined PI3K Inhibitor and Eribulin Enhances Anti-Tumor Activity in Preclinical Models of Paclitaxel-Resistant, PIK3CA-Mutated Endometrial Cancer.
Jeong, Yeong Gyu; Katuwal, Nar Bahadur; Kang, Min Sil; Ghosh, Mithun; Hong, Sa Deok; Park, Seong Min; Kim, Seul-Gi; Kim, Tae Hoen; Moon, Yong Wha.
Afiliação
  • Jeong YG; Department of Biomedical Science, The Graduate School, CHA University, Seongnam-si 13488, Republic of Korea.
  • Katuwal NB; Department of Biomedical Science, The Graduate School, CHA University, Seongnam-si 13488, Republic of Korea.
  • Kang MS; Department of Biomedical Science, The Graduate School, CHA University, Seongnam-si 13488, Republic of Korea.
  • Ghosh M; Department of Biomedical Science, The Graduate School, CHA University, Seongnam-si 13488, Republic of Korea.
  • Hong SD; Department of Biomedical Science, The Graduate School, CHA University, Seongnam-si 13488, Republic of Korea.
  • Park SM; Department of Biomedical Science, The Graduate School, CHA University, Seongnam-si 13488, Republic of Korea.
  • Kim SG; Hematology and Oncology, Department of Internal Medicine, CHA Bundang Medical Center, CHA University, Seongnam-si 13496, Republic of Korea.
  • Kim TH; Department of Pathology, CHA Bundang Medical Center, CHA University, Seongnam-si 13496, Republic of Korea.
  • Moon YW; Hematology and Oncology, Department of Internal Medicine, CHA Bundang Medical Center, CHA University, Seongnam-si 13496, Republic of Korea.
Cancers (Basel) ; 15(19)2023 Oct 08.
Article em En | MEDLINE | ID: mdl-37835582
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article